IL-23 signalling as a putative novel therapeutic target in human colorectal cancer - Oxford Talks

IL-23 signalling as a putative novel therapeutic target in human colorectal cancer

Abstract not yet added

Date: 21 February 2019, 14:30
Venue:
Kennedy Institute of Rheumatology
Headington OX3 7FY
See location on maps.ox

Details: Lecture Theatre
Speaker: Dr Elizabeth Mann
Organiser: Dr Carolina Arancibia (University of Oxford)
Organiser contact email address: carolina.arancibia@ndm.ox.ac.uk
Part of: BRC3 Gastroenterology and Mucosal Immunity Theme Seminars
Topics:
Booking required?: Not required
Audience: Members of the University only
Editor: Jayne Jefferies